AP-2 is the crucial clathrin adaptor protein for CD4 downmodulation by HIV-1 Nef in infected primary CD4+ T cells

Journal of Virology

Volumn 89, Issue 24, 2015, Pages 12518-12524

  Gondim, Marcos Vinicius ^a,b,d   Wiltzer Bach, Linda ^c   Maurer, Brigitte ^c   Banning, Carina ^b   Arganaraz, Enrique ^d   Schindler, Michael ^a,b,c  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d UNIVERSITY OF BRASILIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACOT8 PROTEIN; ADAPTOR PROTEIN; ADENOSINE TRIPHOSPHATASE; AP 1 PROTEIN; AP 2 PROTEIN; AP 3 PROTEIN; BETA COP PROTEIN; CD4 ANTIGEN; CLATHRIN; NEF PROTEIN; SHORT HAIRPIN RNA; THIOL ESTER HYDROLASE; UNCLASSIFIED DRUG; V1H PROTEIN; NEF PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1;

ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DOWN REGULATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; BIOSYNTHESIS; GENE SILENCING; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; METABOLISM; PATHOLOGY;

ADAPTOR PROTEIN COMPLEX 2; ANTIGENS, CD4; CD4-POSITIVE T-LYMPHOCYTES; DOWN-REGULATION; GENE KNOCKDOWN TECHNIQUES; HIV INFECTIONS; HIV-1; HUMANS; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84949802447     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01838-15     Document Type: Article

References (32)

1. Lama J. 2003. The physiological relevance of CD4 receptor downmodulation during HIV infection. Curr HIV Res 1:167-184. http://dx.doi.org/10.2174/1570162033485276.
2. Stoddart CA, Geleziunas R, Ferrell S, Linquist-Stepps V, Moreno ME, Bare C, Xu WD, Yonemoto W, Bresnahan PA, McCune JM, Greene WC. 2003. Human immunodeficiency virus type 1 Nefmediated downregulation of CD4 correlates with Nef enhancement of viral pathogenesis. J Virol 77:2124-2133. http://dx.doi.org/10.1128/JVI.77.3.2124-2133.2003.
3. Arganaraz ER, Schindler M, Kirchhoff F, Cortes MJ, Lama J. 2003. Enhanced CD4 down-modulation by late stage HIV-1 nef alleles is associated with increased env incorporation and viral replication. J Biol Chem 278:33912-33919. http://dx.doi.org/10.1074/jbc.M303679200.
4. Lundquist CA, Tobiume M, Zhou J, Unutmaz D, Aiken C. 2002. Nef-mediated downregulation of CD4 enhances human immunodeficiency virus type 1 replication in primary T lymphocytes. J Virol 76:4625-4633.http://dx.doi.org/10.1128/JVI.76.9.4625-4633.2002.
5. Greenberg ME, Bronson S, Lock M, Neumann M, Pavlakis GN, Skowronski J. 1997. Co-localization of HIV-1 Nef with the AP-2 adaptor protein complex correlates with Nef-induced CD4 down-regulation. EMBO J 16:6964-6976. http://dx.doi.org/10.1093/emboj/16.23.6964.
6. Jin YJ, Cai CY, Zhang XP, Zhang HT, Hirst JA, Burakoff SJ. 2005. HIV nef-mediated CD4 down-regulation is adaptor protein complex 2 dependent. J Immunol 175:3157-3164. http://dx.doi.org/10.4049/jimmunol.175.5.3157.
7. Piguet V, Gu F, Foti M, Demaurex N, Gruenberg J, Carpentier JL, Trono D. 1999. Nef-induced CD4 degradation: a diacidic-based motif in Nef functions as a lysosomal targeting signal through the binding of beta-COP in endosomes. Cell 97:63-73. http://dx.doi.org/10.1016/S0092-8674(00)80715-1.
8. Lu XB, Yu HF, Liu SH, Brodsky FM, Peterlin BM. 1998. Interactions between HIV1 Nef and vacuolar ATPase facilitate the internalization of CD4. Immunity 8:647-656. http://dx.doi.org/10.1016/S1074-7613(00)80569-5.
9. Craig HM, Reddy TR, Riggs NL, Dao PP, Guatelli JC. 2000. Interactions of HIV-1 Nef with the mu subunits of adaptor protein complexes 1, 2, and 3: role of the dileucine-based sorting motif. Virology 271:9-17. http://dx.doi.org/10.1006/viro.2000.0277.
10. Liu LX, Margottin F, LeGall S, Schwartz O, Selig L, Benarous R, Benichou S. 1997. Binding of HIV-1 Nef to a novel thioesterase enzyme correlates with Nef-mediated CD4 down-regulation. J Biol Chem 272: 13779-13785. http://dx.doi.org/10.1074/jbc.272.21.13779.
11. Pizzato M, Helander A, Popova E, Calistri A, Zamborlini A, Palu G, Gottlinger HG. 2007. Dynamin 2 is required for the enhancement of HIV-1 infectivity by Nef. Proc Natl Acad Sci U S A 104:6812-6817. http://dx.doi.org/10.1073/pnas.0607622104.
12. Landi A, Vermeire J, Iannucci V, Vanderstraeten H, Naessens E, Bentahir M, Verhasselt B. 2014. Genome-wide shRNA screening identifies host factors involved in early endocytic events for HIV-1-induced CD4 down-regulation. Retrovirology 11:118. http://dx.doi.org/10.1186/s12977-014-0118-4.
13. Janvier K, Craig H, Le Gall S, Benarous R, Guatelli J, Schwartz O, Benichou S. 2001. Nef-induced CD4 downregulation: a diacidic sequence in human immunodeficiency virus type 1 Nef does not function as a protein sorting motif through direct binding to beta-COP. J Virol 75:3971-3976.http://dx.doi.org/10.1128/JVI.75.8.3971-3976.2001.
14. Schaefer MR, Wonderlich ER, Roeth JF, Leonard JA, Collins KL. 2008. HIV-1 Nef targets MHC-I and CD4 for degradation via a final common beta-COP-dependent pathway in T cells. PLoS Pathog 4:e1000131. http://dx.doi.org/10.1371/journal.ppat.1000131.
15. Roeth JF, Collins KL. 2006. Human immunodeficiency virus type 1 Nef: adapting to intracellular trafficking pathways. Microbiol Mol Biol Rev 70:548-563. http://dx.doi.org/10.1128/MMBR.00042-05.
16. Banning C, Votteler J, Hoffmann D, Koppensteiner H, Warmer M, Reimer R, Kirchhoff F, Schubert U, Hauber J, Schindler M. 2010. A flow cytometry-based FRET assay to identify and analyse protein-protein interactions in living cells. PLoS One 5:e9344. http://dx.doi.org/10.1371/journal.pone.0009344.
17. Hagen N, Bayer K, Rosch K, Schindler M. 2014. The intraviral protein interaction network of hepatitis C virus. Mol Cell Proteomics 13:1676-1689.http://dx.doi.org/10.1074/mcp.M113.036301.
18. Schindler M, Munch J, Kutsch O, Li H, Santiago ML, Bibollet-Ruche F, Muller-Trutwin MC, Novembre FJ, Peeters M, Courgnaud V, Bailes E, Roques P, Sodora DL, Silvestri G, Sharp PM, Hahn BH, Kirchhoff F. 2006. Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell 125:1055-1067. http://dx.doi.org/10.1016/j.cell.2006.04.033.
19. Koppensteiner H, Hohne K, Gondim MV, Gobert FX, Widder M, Gundlach S, Heigele A, Kirchhoff F, Winkler M, Benaroch P, Schindler M. 2014. Lentiviral Nef suppresses iron uptake in a strain specific manner through inhibition of Transferrin endocytosis. Retrovirology 11:1. http://dx.doi.org/10.1186/1742-4690-11-1.
20. Craig HM, Pandori MW, Guatelli JC. 1998. Interaction of HIV-1 Nef with the cellular dileucine-based sorting pathway is required for CD4 down-regulation and optimal viral infectivity. Proc Natl Acad Sci U S A 95:11229-11234. http://dx.doi.org/10.1073/pnas.95.19.11229.
21. Chaudhuri R, Lindwasser OW, Smith WJ, Hurley JH, Bonifacino JS. 2007. Downregulation of CD4 by human immunodeficiency virus type 1 Nef is dependent on clathrin and involves direct interaction of Nef with the AP2 clathrin adaptor. J Virol 81:3877-3890. http://dx.doi.org/10.1128/JVI.02725-06.
22. Schindler M, Wurfl S, Benaroch P, Greenough TC, Daniels R, Easterbrook P, Brenner M, Munch J, Kirchhoff F. 2003. Down-modulation of mature major histocompatibility complex class II and up-regulation of invariant chain cell surface expression are well-conserved functions of human and simian immunodeficiency virus nef alleles. J Virol 77:10548-10556.http://dx.doi.org/10.1128/JVI.77.19.10548-10556.2003.
23. Jin YJ, Cai CY, Zhang XP, Burakoff SJ. 2008. Lysine 144, a ubiquitin attachment site in HIV-1 Nef, is required for Nef-mediated CD4 down-regulation. J Immunol 180:7878-7886. http://dx.doi.org/10.4049/jimmunol.180.12.7878.
24. Bentham M, Mazaleyrat S, Harris M. 2003. The di-leucine motif in the cytoplasmic tail of CD4 is not required for binding to human immunodeficiency virus type 1 Nef, but is critical for CD4 down-modulation. J Gen Virol 84:2705-2713. http://dx.doi.org/10.1099/vir.0.19274-0.
25. Bentham M, Mazaleyrat S, Harris M. 2006. Role of myristoylation and N-terminal basic residues in membrane association of the human immunodeficiency virus type 1 Nef protein. J Gen Virol 87:563-571. http://dx.doi.org/10.1099/vir.0.81200-0.
26. Grzesiek S, Stahl SJ, Wingfield PT, Bax A. 1996. The CD4 determinant for downregulation by HIV-1 Nef directly binds to Nef. Mapping of the Nef binding surface by NMR. Biochemistry 35:10256-10261.
27. Aiken C, Konner J, Landau NR, Lenburg ME, Trono D. 1994. Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 76:853-864. http://dx.doi.org/10.1016/0092-8674(94)90360-3.
28. Greenberg ME, Iafrate AJ, Skowronski J. 1998. The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes. EMBO J 17:2777-2789. http://dx.doi.org/10.1093/emboj/17.10.2777.
29. Lee MTM, Coburn GA, McClure MO, Cullen BR. 2003. Inhibition of human immunodeficiency virus type 1 replication in primary macrophages by using Tat-or CCR5-specific small interfering RNAs expressed from a lentivirus vector. J Virol 77:11964-11972. http://dx.doi.org/10.1128/JVI.77.22.11964-11972.2003.
30. Subach OM, Cranfill PJ, Davidson MW, Verkhusha VV. 2011. An enhanced monomeric blue fluorescent protein with the high chemical stability of the chromophore. PLoS One 6:e28674. http://dx.doi.org/10.1371/journal.pone.0028674.
31. Munch J, Rajan D, Schindler M, Specht A, Rucker E, Novembre FJ, Nerrienet E, Mueller-Trutwin MC, Peeters M, Hahn BH, Kirchhoff F. 2007. Nef-mediated enhancement of virion infectivity and stimulation of viral replication are fundamental properties of primate lentiviruses. J Virol 81:13852-13864. http://dx.doi.org/10.1128/JVI.00904-07.
32. Wildum S, Schindler M, Munch J, Kirchhoff F. 2006. Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection. J Virol 80:8047-8059. http://dx.doi.org/10.1128/JVI.00252-06.